By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cerecor Inc. 

2400 Boston Street, Suite 324

Baltimore  Maryland  21224  U.S.A.
Phone: 410-522-8707 Fax: n/a


Start Up

Company News
Cerecor Inc. Announces Separation Of Units Sold In IPO 11/13/2015 12:24:29 PM
Cerecor Inc. Announces Pricing Of Initial Public Offering 10/15/2015 8:28:57 AM
Cerecor Inc. Initiates Phase II Study For CERC-301, An Antidepressant Product Candidate With Potential For Rapid Onset Of Effect 9/3/2015 10:51:50 AM
Cerecor Inc. Announces Updates To Management Team And Board Of Directors 5/29/2015 11:52:08 AM
Cerecor Inc. Provides Update On CERC-301 Development In Major Depressive Disorder 3/20/2015 9:57:19 AM
Cerecor Inc. Bolsters Clinical Pipeline With Acquisition Of Phase 2-Ready Kappa Opioid Receptor Antagonist From Eli Lilly (LLY) 2/20/2015 8:55:57 AM
Cerecor Inc. To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/5/2014 8:05:28 AM
Cerecor Inc. Receives Fast Track Designation For CERC-301 For The Treatment Of Major Depressive Disorder 11/25/2013 12:35:12 PM
Cerecor Inc. Announces Initiation of Phase 2 Study for CERC-301, an Oral Rapid-acting Antidepressant Candidate 11/8/2013 10:00:47 AM
Cerecor Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/2/2013 7:33:47 AM